Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
about
A Blueprint for HIV Vaccine DiscoveryResolve, revise, and relax: the 3 Rs of B cell repertoire adjustmentHIV-1 neutralizing antibodies: understanding nature's pathwaysHIV-1 antibodies from infection and vaccination: insights for guiding vaccine designVirological features associated with the development of broadly neutralizing antibodies to HIV-1Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 InfectionMaturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyAutoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10Progress in HIV-1 vaccine development.Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activityHumanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion.Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primatesHumoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV InfectionPrevalence of broadly neutralizing antibody responses during chronic HIV-1 infection.Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination.Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodiesB-cell-lineage immunogen design in vaccine development with HIV-1 as a case studyIsolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrumVaccines that stimulate T cell immunity to HIV-1: the next step9G4+ antibodies isolated from HIV-infected patients neutralize HIV-1 and have distinct autoreactivity profiles.Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses.HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy.Exceptional Antibodies Produced by Successive Immunizations.Altered Ig hypermutation pattern and frequency in complementary mouse models of DNA polymerase ζ activity.Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine DesignNeutralizing antibodies to HIV-1 induced by immunization.Role of IL-21 and IL-21 receptor on B cells in HIV infection.Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1Anti-HIV B Cell lines as candidate vaccine biosensors.Lessons learned from HIV-1 vaccine trials: new priorities and directions
P2860
Q26829865-47E04397-01D5-4066-BAEF-CE6138C6BAD7Q26852927-26D22032-08C2-4E88-B546-520801C74D31Q27000480-1817B135-42B0-4781-98D0-FEC7D6838151Q27022055-A6B33C78-05FF-4498-9E92-B0AF926F1880Q27025177-FBABCB7E-8F93-44A1-9286-DD5BE315BDB9Q27312171-8D2156BA-26FB-4CBF-AA63-C4179AF5B686Q27640572-423A3558-0F92-42A0-8637-CEE4F36B9491Q27644415-B3177FFE-7E07-4052-91DF-14C281FE6BBFQ27680125-ABE041C3-A9DD-4811-806D-E99A57B1550EQ27693849-1C1EA51E-E954-4527-9749-FD74163303F2Q28602877-6D077764-7BA8-4529-9C86-18AC37D4C832Q28730532-348CB21D-6B20-4550-8B98-B087F4163E82Q30234773-E796077A-2AB9-46FC-AE1F-7196FE74D5BFQ30490942-2AF857E0-1D89-4EF4-8A4D-47AA844CA95FQ31151010-1367112C-4433-4F8C-B849-9A1C3E1724F2Q33355730-EAB9E3BD-8262-42E0-A00C-C2FB3E8221CEQ33620546-8D137A86-2F26-4862-BE83-1FDA8F291797Q33702217-4B595240-A55C-4D68-B104-E91D6526710CQ33922778-96C2D1F7-4EB9-4EB5-9DA4-0E898C5752E8Q34022578-55916900-C1AB-4BAD-8A70-5F80076927FEQ34177732-4B3EB5EF-2386-4481-95D0-AE488467E167Q34273373-56D46291-5FC5-4311-8508-8A01C5F7F926Q34280115-CE873110-065C-4FFE-82AA-37F06790A367Q35073079-BDAE72B0-C519-4791-B39E-57EE4344DFF6Q35081119-A17FE89F-D157-402E-8493-2AC5AC729F81Q35088691-E3997016-48DF-4183-8DB7-394E7FCE294CQ35172770-F390BE08-9AB9-4923-80D0-9449D4C73848Q35706462-60D016B0-DAE3-4C40-AAF3-D1E53562A5B6Q35825170-1A5AE1B8-F8EC-447B-9F46-9DC4FA2ADED0Q35862420-A304D352-3F82-4034-BD40-59135FC00126Q35980902-458C99A8-004D-462B-A2A4-76BEDE8DFD99Q36010933-6F992440-CDCA-43E0-95B7-EE292C71580EQ36246403-6DC70A78-B875-4065-AD24-E42F9D99F62FQ36447540-4AC355DD-FE46-43D9-8DBA-C24305ADF085Q36603515-60B7F320-5B2E-4095-99BC-F0CF85B7464AQ36670538-11655B37-9FE0-4DD5-AD13-487CF6F9A957Q36759963-DA5FBB6B-74C2-4B6A-84E5-3A04834D714AQ36760169-ABF6C27C-C5EF-4E41-B003-FD539583D32DQ36766704-300FC338-3C02-4AD5-B8F1-02B2217EAAC0Q36839817-B944D440-8B73-477E-8FFA-EDEFDF7A0420
P2860
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
@ast
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
@en
type
label
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
@ast
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
@en
prefLabel
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
@ast
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
@en
P2860
P1476
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
@en
P2093
Laurent Verkoczy
M Anthony Moody
P2860
P304
P356
10.1016/J.COI.2011.04.003
P577
2011-04-27T00:00:00Z